NEVVI Medicare utilization intelligence

← back

CHAN, PAULMD NPI 1386630879 Clinician

Urology · ARLINGTON, TX

Specialty Urology — from billed Medicare claims
In practice about 33 years since medical school (class of 1993, self-reported to CMS)
Location ARLINGTON, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 28 codes billed · 2,478 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
UROLOGY PARTNERS OF NORTH TEXAS, PLLC
2020–2026
MEDICAL CLINIC OF NORTH TEXAS, PLLC
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2019-07

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
36415 Insertion of needle into vein for collection of blood sample
84153 Psa (prostate specific antigen) measurement, total
51798 Ultrasound measurement of bladder capacity after voiding
81003 Automated urinalysis test
J0696 Injection, ceftriaxone sodium, per 250 mg
96372 Injection of drug or substance under skin or into muscle
87801 Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
76872 Ultrasound scan of pelvic region through rectum
55700 Biopsy of prostate gland
87481 Detection test for candida species (yeast), amplified probe technique
87529 Detection test by nucleic acid for herpes simplex virus, amplified probe technique
87798 Detection test by nucleic acid for organism, amplified probe technique
52000 Diagnostic exam of bladder and urethra using an endoscope
84403 Testosterone (hormone) level, total
82670 Measurement of total estradiol (hormone)
85014 Red blood cell concentration measurement
85018 Blood count, hemoglobin
87496 Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique
87500 Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
87532 Detection test by nucleic acid for herpes virus-6, amplified probe technique
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
87651 Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
11980 Placement of hormone pellet under skin
J3490 Unclassified drugs

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.